Clostridium Difficile Infection — ACX-362E [Ibezapolstat] for Oral Treatment of Clostridioides Difficile Infection
Citation(s)
ACX-362E [Ibezapolstat] for Oral Treatment of Clostridioides Difficile Infection: A Phase 2A Open-Label Segment Followed by a Phase 2B Double-Blind Vancomycin-Controlled Segment